Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 23 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 9176122

    Biomarkers for predicting response to immunosuppressive therapy

    United States Department of Veteran Affairs · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  2. US 9168262

    Estriol therapy for multiple sclerosis and other autoimmune diseases

    The Regents of the University of California · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  3. US 9161935

    Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  4. US 9125923

    Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  5. US 9102752

    Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

    United Biomedical, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  6. US 9095612

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  7. US 9090589

    Specific nNOS inhibitors for the therapy and prevention of human melanoma

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  8. US 9074185

    Adoptive cell therapy with young T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  9. US 9066943

    Use of botulinum toxin therapy for treatment of urological neurological conditions

    The Regents of the University of Colorado · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  10. US 9040721

    Halogenated compounds for Photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted May 26, 2015 · Expires May 21, 2035

    granted

  11. US 9034588

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  12. US 8999290

    Papillomavirus pseudoviruses for detection and therapy of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  13. US 8999294

    Nanoparticles for use in tumor diagnosis and therapy

    The Board of Regents of the University of Texas System · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  14. US 8986701

    Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  15. US 8968234

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  16. US 8962593

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  17. US 8962797

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  18. US 8957047

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  19. US 8945108

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  20. US 8911722

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  21. US 8883500

    Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

    Northwestern University · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  22. US 8859520

    Methods for therapy of neurodegenerative disease of the brain

    The Regents of the University of California · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  23. US 8852936

    Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

    Laurantis Pharma Oy · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  24. US 8853277

    Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.